7-Methyl-8-quinoxalinesulfonyl Chloride - CAS 17999-75-6
Catalog: |
BB056515 |
Product Name: |
7-Methyl-8-quinoxalinesulfonyl Chloride |
CAS: |
17999-75-6 |
Synonyms: |
7-methylquinoline-8-sulfonyl chloride; 7-METHYL-QUINOLINE-8-SULFONYL CHLORIDE; 7-Methyl-8-quinoxalinesulfonyl Chloride; 7-methylquinoline-8-sulfonylchloride; 7-Methyl-8-quinolinesulfonyl chloride |
IUPAC Name: | 7-methylquinoline-8-sulfonyl chloride |
Description: | 7-Methyl-8-quinoxalinesulfonyl Chloride similar to other quinoxalinesulfonyl compounds can be used in the preparation of 8-mercaptoquinoline derivatives. In addition, the compound itself has the potential to inhibit tyrosine kinases. |
Molecular Weight: | 241.69 |
Molecular Formula: | C10H8ClNO2S |
Canonical SMILES: | CC1=C(C2=C(C=CC=N2)C=C1)S(=O)(=O)Cl |
InChI: | InChI=1S/C10H8ClNO2S/c1-7-4-5-8-3-2-6-12-9(8)10(7)15(11,13)14/h2-6H,1H3 |
InChI Key: | IBKAMDKVGHVQEV-UHFFFAOYSA-N |
References: | Ragheb, A. et al. J. Serb. Chem., 52, 697 (1987); Lai, J. et al. Synthet. Comm., 33, 3427 (2003); Yvonne, F. et al. Medicin. Res. Rev., 25, 310 (2005). |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P260, P264, P270, P280, P301+P317, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P330, P363, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
WO-2021249969-A1 | Combination product for the treatment of cancer diseases | 20200610 |
WO-2020127960-A1 | Disubstituted alkyne derivatives | 20181221 |
TW-202039425-A | Disubstituted alkyne derivatives , pharmaceutical composition,and set comprising the same, and process for manufacturing the same | 20181221 |
AU-2019408406-A1 | Disubstituted alkyne derivatives | 20181221 |
CA-3120053-A1 | Disubstituted alkyne derivatives | 20181221 |
EP-3898588-A1 | Disubstituted alkyne derivatives | 20181221 |
AU-2018253069-A1 | Liver X receptors (LXR) modulators | 20170410 |
BR-112019020075-A2 | compound and pharmaceutical composition | 20170410 |
CA-3057736-A1 | Liver x receptors (lxr) modulators | 20170410 |
CN-110546144-A | Liver X Receptor (LXR) modulators | 20170410 |
Complexity: | 325 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 240.9964274 |
Formal Charge: | 0 |
Heavy Atom Count: | 15 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 240.9964274 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 55.4Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.6 |
-
Catalog: BB016437
2-amino-3-{pyrrolo[2,1-f][1,2,4]triazin-5-yl}propanenitrile
Detail
-
Catalog: BB002009
Ethylenesulfate
Detail
-
Catalog: BB043274
Ethylferrocene
Detail
-
Catalog: BB016398
4-chloro-6-methylimidazo[2,1-f][1,2,4]triazine
Detail
-
Catalog: BB077194
(S)-(-)-1,2-epoxydecane
Detail
-
Catalog: BB014781
1,4-Benzodioxane-6-carbonitrile
Detail
-
Catalog: BB012200
8-(tetramethyl-1,3,2-dioxaborolan-2-yl)-4H-chromen-4-one
Detail
-
Catalog: BB076899
Cucurbit[5]uril
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS